At the outset of clinical trials, Pfizer registers those studies on clinicaltrials.gov, the U.S. National Institutes of Health’s publicly available clinical trials registry and database. After the completion of those studies, we work to provide results on clinicaltrials.gov and EudraCT within one year of study completion.
| 2013 - 2016 | |
| Total Number of Registrations* | 423 |
| Total Number of Results* | 375 |
| Percentage of On-Time Compliant Registrations with FDAAA** | 95% |
| Percentage of On-Time Compliant Results with FDAAA** | 89.3% |
*Pfizer posts registrations and results beyond the scope required by FDAAA
**FDAAA is the Food and Drug Administration Amendment Act
Under FDAAA, sponsors are required to register their studies within 21 days of the first subject, first visit (when the first participant officially enrolls in the study). Results must be posted within one year of study completion for marketed products. For investigational medicines, results are posted within 30 days of regulatory approval.